Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-26

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves Cranbury Pharmaceuticals' dexmethylphenidate hydrochloride as an original-application generic product (for attention-deficit/hyperactivity disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)